MX2009006634A - Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer. - Google Patents

Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer.

Info

Publication number
MX2009006634A
MX2009006634A MX2009006634A MX2009006634A MX2009006634A MX 2009006634 A MX2009006634 A MX 2009006634A MX 2009006634 A MX2009006634 A MX 2009006634A MX 2009006634 A MX2009006634 A MX 2009006634A MX 2009006634 A MX2009006634 A MX 2009006634A
Authority
MX
Mexico
Prior art keywords
sup
hydrogen
halo
cancer
treatment
Prior art date
Application number
MX2009006634A
Other languages
English (en)
Spanish (es)
Inventor
James Robert Henry
Yang Wang
Hong-Yu Li
Harold Burns Brooks
Joyce Z Crich
Melissa Kate Slater
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2009006634A publication Critical patent/MX2009006634A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2009006634A 2006-12-21 2007-12-11 Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer. MX2009006634A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87130206P 2006-12-21 2006-12-21
PCT/US2007/087044 WO2008076704A1 (en) 2006-12-21 2007-12-11 Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer

Publications (1)

Publication Number Publication Date
MX2009006634A true MX2009006634A (es) 2009-06-30

Family

ID=39186811

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006634A MX2009006634A (es) 2006-12-21 2007-12-11 Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer.

Country Status (14)

Country Link
US (1) US8101628B2 (cg-RX-API-DMAC10.html)
EP (1) EP2125793B1 (cg-RX-API-DMAC10.html)
JP (1) JP5166441B2 (cg-RX-API-DMAC10.html)
KR (1) KR101088291B1 (cg-RX-API-DMAC10.html)
CN (1) CN101563342B (cg-RX-API-DMAC10.html)
AT (1) ATE479680T1 (cg-RX-API-DMAC10.html)
AU (1) AU2007334039B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0721045A2 (cg-RX-API-DMAC10.html)
CA (1) CA2671738A1 (cg-RX-API-DMAC10.html)
DE (1) DE602007008952D1 (cg-RX-API-DMAC10.html)
EA (1) EA016177B1 (cg-RX-API-DMAC10.html)
ES (1) ES2349169T3 (cg-RX-API-DMAC10.html)
MX (1) MX2009006634A (cg-RX-API-DMAC10.html)
WO (1) WO2008076704A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2125794T1 (sl) 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
EA016781B1 (ru) * 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds
CN108853111B (zh) * 2018-08-07 2020-06-05 浙江大学 一种组合物在制备治疗吉非替尼肝脏毒性药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
WO2004063192A1 (en) * 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
JP2007533602A (ja) * 2003-07-31 2007-11-22 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 置換ベンゾチオフェン化合物及びそれらの使用
AU2005316312B2 (en) 2004-12-17 2009-10-22 Amgen, Inc. Aminopyrimidine compounds and methods of use
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8008481B2 (en) * 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
SI2125794T1 (sl) 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
EA016781B1 (ru) 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds

Also Published As

Publication number Publication date
EA016177B1 (ru) 2012-02-28
KR101088291B1 (ko) 2011-11-30
AU2007334039A1 (en) 2008-06-26
BRPI0721045A2 (pt) 2014-07-29
US20100076001A1 (en) 2010-03-25
WO2008076704A1 (en) 2008-06-26
ES2349169T3 (es) 2010-12-28
KR20090086114A (ko) 2009-08-10
EA200970615A1 (ru) 2009-10-30
CN101563342A (zh) 2009-10-21
ATE479680T1 (de) 2010-09-15
US8101628B2 (en) 2012-01-24
JP2010513552A (ja) 2010-04-30
EP2125793B1 (en) 2010-09-01
CA2671738A1 (en) 2008-06-26
EP2125793A1 (en) 2009-12-02
CN101563342B (zh) 2012-09-05
AU2007334039B2 (en) 2012-02-16
JP5166441B2 (ja) 2013-03-21
DE602007008952D1 (de) 2010-10-14

Similar Documents

Publication Publication Date Title
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
TN2009000444A1 (en) Combination therapy with a compound acting as a plateletadp receptor inhibitor
EP4378482A3 (en) Dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates
TW200833663A (en) Therapeutic agents
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
PT1678166E (pt) Inibidores de proteína-quinase
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
MY138352A (en) Benzothiazole derivatives
PT1696905E (pt) 2-aminotetralinas substituídas para o tratamento preventivo da doença de parkinson
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
GB0112348D0 (en) Compounds
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
TW200740787A (en) (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones
IL194057A0 (en) Pyrimidine, quinazoline, pteridine and triazine derivatives
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
MX2007013624A (es) Inhibidores de proteina cinasa.
TW200716547A (en) Piperidin-4-yl-amide derivatives
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
TW200626158A (en) Naphthaline derivatives
TW200639156A (en) New compounds
EA200970615A1 (ru) Соединения имидазолидинониламинопиримидина для лечения рака
MX2009006635A (es) Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer.

Legal Events

Date Code Title Description
FG Grant or registration